Exercise duration and peak systolic blood pressure are predictive of mortality in ambulatory patients with mild-moderate chronic heart failure

Cardiology

Volumn 104, Issue 4, 2005, Pages 221-226

  Williams, Simon G ^a   Jackson, Mark ^b   Ng, Leong L ^c   Barker, Diane ^d   Patwala, Ashish ^b   Tan, Lip Bun ^d  

^a WYTHENSHAWE HOSPITAL   (United Kingdom)

^b LIVERPOOL HEART AND CHEST HOSPITAL   (United Kingdom)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

^d UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Chronic heart failure; Exercise duration; Systolic blood pressure

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; AMINO TERMINAL SEQUENCE; ARTICLE; BLOOD SAMPLING; CAUSE OF DEATH; COHORT ANALYSIS; CONFIDENCE INTERVAL; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; FOLLOW UP; HEART FAILURE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONBIOLOGICAL MODEL; OXYGEN CONSUMPTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; VENOUS BLOOD;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD PRESSURE; CHRONIC DISEASE; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; OXYGEN CONSUMPTION; PHYSICAL ENDURANCE; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RESEARCH DESIGN; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; SURVIVAL ANALYSIS; SYSTOLE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 26044458230     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000088257     Document Type: Article

References (31)

1. Sanderson JE, Tse TF: Heart failure: a global disease requiring a global response. Heart 2003;89:585-586.
2. MERIT-HF Study Group: Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomised interventional trial in chronic heart failure (MERIT-HF). Lancet 1999;353:2001-2007.
3. Cohn JN, Johnson GR, Shabetai R, Loeb H, Tristani F, Rector T, Smith R, Fletcher R: Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. The V-HeFT VA Cooperative Studies Group. Circulation 1993;87(suppl 6):5-16.
4. Myers J, Gullestad L: The role of exercise testing and gas-exchange measurement in the prognostic assessment of patients with heart failure. Curr Opin Cardiol 1998;13:145-155.
5. Richards AM, Nicholls MG, Yandle TG, Frampton C, Espiner A, Turner JG, Buttimore RC, Lainchbury JG, Elliott JM, Ikram H, Crozier IG, Smyth DW: Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin, new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation 1998;97:1921-1929.
6. Gardner RS, Ozlap F, Murday AJ, Robb SD, McDonagh TA: N-terminal pro-brain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure. Eur Heart J 2003;24:1735-1743.
7. Koglin J, Pehlivanli S, Schwaiblmair M, Vogeser M, Cremer P, von Scheidt W: Role of brain natriuretic peptide in risk stratification of patients with chronic heart failure. J Am Coll Cardiol 2001;38:1934-1941.
8. Zugck C, Haunstetter A, Kruger C, Kell R, Schellberg D, Kubler W, Haass M: Impact of beta-blocker treatment on the prognostic value of currently used risk predictors in congestive heart failure. J Am Coll Cardiol 2002;39:1615-1622.
9. Isnard R, Pousset F, Chafirovskaia O, Carayon A, Hulot JS, Thomas D, Komajda M: Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure. Am Heart J 2003;146:729-735.
10. Swedberg K: Exercise testing in heart failure. A critical review. Drugs 1994;47(suppl 4):14-24.
11. Udelson JE, Konstam MA: Relation between left ventricular remodeling and clinical outcomes in heart failure patients with left ventricular systolic dysfunction. J Card Fail 2002;8(suppl 6):S465-S471.
12. Konstam MA, Udelson JE, Anand IS, Cohn JN: Ventricular remodeling in heart failure: a credible surrogate endpoint. J Card Fail 2003;9:350-353.
13. Williams SG, Cooke GA, Wright DJ, Parsons WJ, Riley RL, Marshall P, Tan LB: Peak exercise cardiac power output: a direct indicator of cardiac function strongly predictive of prognosis in chronic heart failure. Eur Heart J 2001;22:1496-1503.
14. Ira S: Human Physiology, ed 5. Dubuque, Wm C Brown Publishers, 1996, pp 414-415.
15. Cohen-Solal A, Tabet JY, Logeart D, Bourgoin P, Tokmakova M, Dahan M: A non-invasively determined surrogate of cardiac power ('circulatory power') at peak exercise is a powerful prognostic factor in chronic heart failure. Eur Heart 2002;23:806-814.
16. Ng LL, Loke I, O'Brien RJ, Squire IB, Davies JE: Plasma urotensin in human systolic heart failure. Circulation 2002;106:2877-2880.
17. Willenheimer RB, Israelsson BA, Cline CM, et al: Simplified echocardiography in the diagnosis of heart failure. Scand Cardiovasc J 1997;31:9-16.
18. Morris CK, Ueshima K, Kawaguchi T, Hideg A, Froelicher VF: The prognostic value of exercise capacity, a review of the literature. Am Heart J 1991;122:1423-1431.
19. Froelicher VF, Perdue S, Pewen W, Risch M: Application of meta-analysis using an electronic spreadsheet to exercise testing in patients after myocardial infarction. Am J Med 1987;83:1045-1054.
20. Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE: Exercise capacity and mortality among men referred for exercise testing. New Engl J Med 2002;346:793-801.
21. ExTraMATCH Collaborative: Exercise training meta-analysis of trials in patients with chronic heart failure. Br Med J 2004:328:189-192.
22. Cotter G, Williams SG, Zered V, Tan LB: The role of cardiac power in heart failure. Curr Opin Cardiol 2003;18:215-222.
23. Filipovsky J, Ducimetiere P, Safar ME: Prognostic significance of exercise blood pressure and heart rate in middle-aged men. Hypertension 1992;20:333-339.
24. Fagard R, Paradaens K, Vanhaecke J: Prognostic significance of exercise versus resting blood pressure in patients with chronic heart failure. J Hypertens 1999;17:1977-1981.
25. Osada N, Chaitman BR, Miller LW, Yip D, Cishek MB, Wolford TL, Donohue TJ: Cardiopulmonary exercise testing identifies low risk patients with heart failure and severely impaired exercise considered for heart transplantation. J Am Coll Cardiol 1998;31:577-582.
26. Horwich TB, Hamilton MA, Fonarow GC: Higher not lower systolic blood pressure is independently associated with improved survival in heart failure. J Card Fail 2004;10(suppl):S98.
27. Shahar E, Lee S, Kim J, Duval S, Barber C, Luepker RV: Hospitalized heart failure: rates and long-term mortality. J Card Fail 2004;10:374-379.
28. Williams SG, Ng LL, O'Brien R, Taylor S, Li YF, Tan LB: Comparison of the plasma N-brain natriuretic peptide, peak oxygen consumption, and left ventricular ejection fraction for severity of chronic heart failure. Am J Cardiol 2004;93:1560-1561.
29. Benge W, Litchfield RL, Marcus ML: Exercise capacity in patients with severe left ventricular dysfunction. Circulation 1980;61:955-959.
30. Tebbe U, Sauer G, Kreuzer H, Neuhaus KL: Left ventricular contraction and relaxation in patients with congestive cardiomyopathy during exercise. Z Kardiol 1982;71:406-412.
31. Williams SG, Ng LL, O'Brien R, Taylor S, Wright DJ, Tan LB: Is plasma N-BNP a good indicator of the functional reserve of failing hearts? The FRESH-BNP study. Eur J Heart Fail 2004;6:891-900.